Trial Profile
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Subcutaneous Injections of ABT-874 vs. Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Briakinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 22 Aug 2011 Additional location (Canada) added as reported by ClinicalTrials.gov.
- 20 Nov 2010 New trial record